On January 28, 2024, Â鶹´«Ã½ announced its intention to list its North American business.
View media releases and relevant documents below.
RESOURCES
Media and investor relations documents
25 March 2025
Amrize To Deliver Next Phase of Value Creation as Standalone Company
28 February 2025
Amrize Form 10 publicly filed with U.S. Securities and Exchange Commission for planned spin-off
21 February 2025
Â鶹´«Ã½â€™s North America business to be named Amrize following planned spin-off
10 January 2025
Â鶹´«Ã½ appoints Board and CEO for planned North American company
06 December 2024
Planned spin-off of Â鶹´«Ã½â€™s North American business expected to occur in H1 2025
28 January 2024
Â鶹´«Ã½ intends to list its North American Business in the U.S.
Meet the Designated Amrize Leadership Team
The leadership appointments will become effective following the execution of the planned spin-off, expected by the end of the first half 2025, subject to shareholder and customary approvals.
Meet the designated AMRIZE Board of Directors
On January 10, 2025, Â鶹´«Ã½ announced the appointment of the designated Board of Directors and CEO for its planned North American company. The appointments will become effective following the execution of the planned spin-off, expected by the end of the first half 2025, subject to shareholder and customary approvals.